Edition:
United Kingdom

People: Regeneron Pharmaceuticals Inc (REGN.OQ)

REGN.OQ on NASDAQ Stock Exchange Global Select Market

372.83USD
7 Dec 2018
Change (% chg)

$-8.86 (-2.32%)
Prev Close
$381.69
Open
$379.28
Day's High
$388.43
Day's Low
$370.35
Volume
323,166
Avg. Vol
270,579
52-wk High
$416.49
52-wk Low
$281.89

Stahl, Neil 

Dr. Neil Stahl, Ph.D., is an Executive Vice President - Research and Development Sciences of the Company. He previously served as Senior Vice President, Research and Development Sciences from January 2007 to December 2014, as Senior Vice President, Preclinical Development and Biomolecular Sciences from December 2000 to December 2007, and as Vice President, Preclinical Development and Biomolecular Sciences from January 2000 to December 2000. He joined the Company in 1991. Before becoming Vice President, Biomolecular Sciences in July 1997, Dr. Stahl was Director, Cytokines and Signal Transduction. Dr. Stahl received his Ph.D. in Biochemistry from Brandeis University.

Basic Compensation

Total Annual Compensation, USD 641,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 8,496,220
Fiscal Year Total, USD 9,137,220

Options Compensation

  Quantity Market Value
Exercisable 225,000 1,370,450.00
Unexercisable 358,332 2,099,320.00
Exercised 50,839 21,619,000.00
Name Fiscal Year Total

P. Roy Vagelos

11,825,400

Leonard Schleifer

26,508,100

Robert Landry

4,794,740

Daniel Van Plew

8,978,600

Neil Stahl

9,137,220

Joseph LaRosa

--
As Of  31 Dec 2017